Friday 6 November 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024.

Revenue: −7.01%
EPS: −101.0%
Free cash flow: +561.9%
Total debt: −90.1%

Quarter to September 2026, against a year earlier

90.48 3.30 +3.79%

Follow SOLV

Alert me

Market cap: $14.8B
P/E: 102×
Fwd P/E: 47.7×
Dividend yield: —
F-score: 5/9
Altman Z: 2.22
Beneish M: −2.07
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Solventum Corporation 10-Q filed Aug 9, 2024

Fiscal Q2 2024 · Period ended Jun 30, 2024 · Filed Aug 9, 2024 · accepted 1:54 PM ET · Document on sec.gov · Filing index

Nothing in this filing raised a red flag. The document itself is on sec.gov.

Read the filing on sec.gov